Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome

The proteome is a major source of therapeutic targets. We conducted a proteome-wide Mendelian randomization (MR) study to identify candidate protein markers and therapeutic targets for colorectal cancer (CRC).